FDA
approval
· 2022-03-28
FDA Approved: RAMELTEON — Supplemental Application (Granules Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Granules Pharmaceuticals' generic ramelteon, enabling market entry for the treatment of insomnia characterized b…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RAMELTEON (RAMELTEON)